Stately Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$12M
- Investors
-
11
Stately Bio General Information
Description
Developer of regenerative medicine technologies designed for therapeutic discovery and manufacturing. The company's platform utilizes a patented machine learning-based live-cell imaging system that measures cell identity, behavior and maturation without labels or dyes, enabling the biotechnology and pharmaceutical sectors to advance cell therapy innovation through non-invasive, real-time analysis of living cells.
Contact Information
Website
www.statelybio.comCorporate Office
- 2625 Middlefield Road
- Suite 365
- Palo Alto, CA 94306
- United States
Corporate Office
- 2625 Middlefield Road
- Suite 365
- Palo Alto, CA 94306
- United States
Stately Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 15-Apr-2025 | $12M | Completed | Generating Revenue |
Stately Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 | ||||||||
| Seed | 2,718,818 | $0.000010 | $3.6 | $3.6 | 1x | $3.6 | 20.19% |
Stately Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Stately Bio Patents
Stately Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12148157-B1 | Platforms, systems, and methods for identifying and monitoring cell states | Active | 01-May-2023 |
Stately Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Stately Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AIX Ventures | Venture Capital | Minority | ||
| Axial (San Francisco) | Venture Capital | Minority | ||
| BoxOne Ventures | Venture Capital | Minority | ||
| Caffeinated Capital | Venture Capital | Minority | ||
| Dimension (United States) | Venture Capital | Minority |
Stately Bio FAQs
-
When was Stately Bio founded?
Stately Bio was founded in 2022.
-
Where is Stately Bio headquartered?
Stately Bio is headquartered in Palo Alto, CA.
-
What is the size of Stately Bio?
Stately Bio has 8 total employees.
-
What industry is Stately Bio in?
Stately Bio’s primary industry is Drug Discovery.
-
Is Stately Bio a private or public company?
Stately Bio is a Private company.
-
What is the current valuation of Stately Bio?
The current valuation of Stately Bio is .
-
What is Stately Bio’s current revenue?
The current revenue for Stately Bio is .
-
How much funding has Stately Bio raised over time?
Stately Bio has raised $12M.
-
Who are Stately Bio’s investors?
AIX Ventures, Axial (San Francisco), BoxOne Ventures, Caffeinated Capital, and Dimension (United States) are 5 of 11 investors who have invested in Stately Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
